Biosecurity issues in synthetic biology have many stakeholders with different perspectives, including the biotechnology industry, academics, government officials. and members of the public.
This report offers an overview of the October 7, 2019 White House Summit on America’s Bioeconomy. The Summit gathered the US' foremost bioeconomy experts, Federal officials, and industry leaders to discuss US bioeconomy leadership, challenges, and opportunities.
Biotechnology has improved humanity, but advances in biotechnology have increased the risk biotechnology could be used to cause economic damage. Biosecurity is now linked to economic security.
This roadmap provides an assessment of the current status and potential of engineering biology. It covers technical challenges and opportunities in the near and long term.